Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation.
Maraviroc intensification for suboptimal CD4⁺ T cell response in a perinatally HIV-infected adolescent.
Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells.
European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection.
HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes.
A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.
Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.